AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,105 | +38.5% | 64,842 | +75.1% | 0.00% | 0.0% |
| Q2 2023 | $946,512 | -13.0% | 37,031 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,088,543 | +45.8% | 36,602 | +32.7% | 0.00% | 0.0% |
| Q4 2022 | $746,504 | +48.4% | 27,587 | +19.4% | 0.00% | – |
| Q3 2022 | $503,000 | -15.6% | 23,101 | +6.0% | 0.00% | – |
| Q2 2022 | $596,000 | – | 21,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |